Safety and Efficacy of Combigan® Ophthalmic Solution in Korea

Study Identifier
190342-040
CT.gov Identifier
NCT01987752
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Ocular Hypertension
    • Study Drug
  • brimonidine tartrate/timolol maleate Ophthalmic Solution
    • Phase
    N/A
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Patients with Open Angle Glaucoma or Ocular Hypertension treated with Combigan® Ophthalmic Solution as standard of care in clinical practice.
    Exclusion Criteria:
    * None.

    Protocol Summary

    This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of Combigan® (brimonidine tartrate/timolol maleate) Ophthalmic Solution in patients with Open Angle Glaucoma or Ocular hypertension with insufficient response to local beta blockers treated as per standard of care in clinical practice.

    Study Locations

    Location
    Status
    Location
    Seoul, Republic of Korea
    Status
    Not applicable